SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 4, 2004
ENHANCE BIOTECH, INC.
(Exact name of issuer as specified in its charter)
DELAWARE
(State or other jurisdiction of incorporation)
000-31653 95-4766094
(Commission File Number) (IRS Employer Identification No.)
666 Third Avenue, New York, NY, 10017
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (212) 561-1716
N/A
(Former name or former address, if changed since last report)
ITEM 1. CHANGES IN CONTROL OF REGISTRANT.
NOT APPLICABLE
ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS.
NOT APPLICABLE
ITEM 3. BANKRUPTCY OR RECEIVERSHIP.
NOT APPLICABLE
ITEM 4. CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANTS
As of June, 4, 2004, the Registrant has appointed new auditors. By
mutual agreement, Registrant and Farber & Hass, LLP. (Registrant's former
independent auditors) terminated the auditor-client relationship. This decision
to terminate the relationship was the result of the projected cost and timing of
completion of Registrant's annual audit from Farber and Hass, LLP.
Registrant provided Farber & Hass, LLP with a copy of the disclosures
it is making herein prior to the filing of this Current Report on Form 8-K with
the Securities and Exchange Commission ("SEC") and requested that Farber & Hass,
LLP furnish the Registrant a letter addressed to the SEC stating whether Farber
& Hass, LLP agrees with the statements made by the Registrant herein and, if
not, stating the respects in which it does not agree. Farber & Hass, LLP's
letter, dated June 4, 2004 is attached as Exhibit 16.1 hereto. Also attached
hereto as Exhibit 16.2 is a copy of Farber & Hass, LLP's letter confirming the
termination of the client-auditor relationship between Farber & Hass, LLP and
Registrant.
There has not been any adverse opinion or disclaimer of opinion issued
by Farber & Hass, LLP on the financial statements since their appointment. The
decision to change auditors was approved by the Board of Directors. There were
no disagreements with the former accountant on any matter of accounting
principles or practices since their appointment.
Simultaneously with the termination of its relationship with Farber &
Hass, LLP, Registrant retained Cacciamatta Accountancy Corporation
("Cacciamatta") as the Registrant's independent auditors. Cacciamatta's address
is 2600 Michelson, Suite 490, Irvine, CA 92612. The Registrant's Board of
Directors approved the appointment of Cacciamatta as the Registrant's
independent accountants on June 4, 2004.
During the most recent fiscal year and subsequent interim period,
Registrant has not consulted with Cacciamatta regarding (i) either the
application of accounting principles to a specified transaction, either
completed or proposed, or the type of audit opinion that might be rendered on
its financial statements, or (ii) any matter that was either the subject of
disagreement on any matter of accounting principles or practices, financial
statement disclosure or auditing scope or procedures or a reportable event (as
defined in Item 304(a)(1)(v) of Regulation S-K).
ITEM 5. OTHER EVENTS.
NOT APPLICABLE
ITEM 6. RESIGNATIONS OF REGISTRANT'S DIRECTORS.
NOT APPLICABLE
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(a) Financial Statements.
None.
(b) Pro Forma Financial Information.
None.
(c) Exhibits.
16.1 Accountant's Letter to SEC dated June 4, 2004
16.2 Accountant's Letter to Registrant dated June 4, 2004
2
ITEM 8. CHANGE IN FISCAL YEAR.
NOT APPLICABLE
ITEM 9. REGULATION FD DISCLOSURE.
NOT APPLICABLE
ITEM 10. AMENDMENTS/WAIVERS TO THE REGISTRANT'S CODE OF ETHICS.
NOT APPLICABLE
ITEM 11. TEMPORARY SUSPENSION OF TRADING UNDER REGISTRANT'S EMPLOYEE BENEFIT
PLANS.
NOT APPLICABLE
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
NOT APPLICABLE
ITEM 13. RECEIPT OF AN ATTORNEY'S WRITTEN NOTICE.
NOT APPLICABLE
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
ENHANCE BIOTECH, INC.,
A Delaware corporation (Registrant)
DATE: JUNE 4, 2004 BY: /S/ CHRISTOPHER EVERY
--------------------------------
CHRISTOPHER EVERY, CHIEF
EXECUTIVE OFFICER
3